Clinical trial
Prospective Study to Assess Patient Satisfaction, Quality of Life and Adverse Events of Patients Using the Biojector Versus Standard Needles for Enfuvirtide Administration
NCT00333736 is registered in ClinicalTrials.gov with Canadian Immunodeficiency Research Collaborative as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective Study to Assess Patient Satisfaction, Quality of Life and Adverse Events of Patients Using the Biojector Versus Standard Needles for Enfuvirtide Administration
- Lead sponsor
- Canadian Immunodeficiency Research Collaborative
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- May 31, 2005
- Completion date
- September 30, 2008
- Enrollment
- 337 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
human immunodeficiency virus